Fenton Mary Kay

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Fenton Mary Kay's trades of Cullinan Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
329.74
Quantity 45,566
Value US$207,166
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-23 2026-02-20
S Sale
22,188 -25.6%
331.83
US$1,227,169 		22,188 -25.6% 331.83 US$1,227,169
2023-07-05 2023-07-05
PrS Proposed sale
45,566
329.74
US$207,166 		45,566 329.74 US$207,166